Sorrento Therapeutics Inc (SRNE) stock is higher by 47.94% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary scoring system, gives SRNE stock a score of 62 out of a possible 100.
That score is mainly influenced by a fundamental score of 85. In addition to the average rating from Wall Street analysts, SRNE stock has a mean target price of 25.5. This means analysts expect the stock to climb 545.57% over the next 12 months. SRNE's score also includes a long-term technical score of 55. The short-term technical score for SRNE is 46.
Click Here to get the full Stock Score Report on Sorrento Therapeutics Inc (SRNE) Stock.
What's Happening with SRNE Stock Today
Sorrento Therapeutics Inc (SRNE) stock has gained 4.64% while the S&P 500 is higher by 0.03% as of 1:41 PM on Wednesday, Dec 11. SRNE is higher by $0.18 from the previous closing price of $3.78 on volume of 5,207,903 shares. Over the past year the S&P 500 has gained 18.84% while SRNE is higher by 47.94%. SRNE lost -$2.25 per share in the over the last 12 months.
